These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28416745)

  • 21. Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors.
    Li ZR; Wang S; Yang L; Yuan XH; Suo FZ; Yu B; Liu HM
    Eur J Med Chem; 2019 Mar; 166():432-444. PubMed ID: 30739825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.
    Zhou C; Kang D; Xu Y; Zhang L; Zha X
    Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases.
    Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R
    J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1.
    Lynch JT; Cockerill MJ; Hitchin JR; Wiseman DH; Somervaille TC
    Anal Biochem; 2013 Nov; 442(1):104-6. PubMed ID: 23911524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The growing structural and functional complexity of the LSD1/KDM1A histone demethylase.
    Marabelli C; Marrocco B; Mattevi A
    Curr Opin Struct Biol; 2016 Dec; 41():135-144. PubMed ID: 27470128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of cell-active lysine specific demethylase 1-selective inhibitors.
    Ueda R; Suzuki T; Mino K; Tsumoto H; Nakagawa H; Hasegawa M; Sasaki R; Mizukami T; Miyata N
    J Am Chem Soc; 2009 Dec; 131(48):17536-7. PubMed ID: 19950987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance.
    Zhang F; Xu D; Yuan L; Sun Y; Xu Z
    Nat Commun; 2014 Dec; 5():5815. PubMed ID: 25519973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
    Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
    J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
    Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Strååt K; Björkholm M; Xu D
    PLoS One; 2008 Jan; 3(1):e1446. PubMed ID: 18197256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
    Laurent B; Shi Y
    Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of lysine-specific demethylase 1 inhibitor peptide by redox-controlled cleavage of a traceless linker.
    Amano Y; Umezawa N; Sato S; Watanabe H; Umehara T; Higuchi T
    Bioorg Med Chem; 2017 Feb; 25(3):1227-1234. PubMed ID: 28065500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of lysine-specific demethylase 1 by the acyclic diterpenoid geranylgeranoic acid and its derivatives.
    Sakane C; Okitsu T; Wada A; Sagami H; Shidoji Y
    Biochem Biophys Res Commun; 2014 Jan; 444(1):24-9. PubMed ID: 24406160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors.
    Ji YY; Lin SD; Wang YJ; Su MB; Zhang W; Gunosewoyo H; Yang F; Li J; Tang J; Zhou YB; Yu LF
    Eur J Med Chem; 2017 Dec; 141():101-112. PubMed ID: 29031059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.
    Lan F; Collins RE; De Cegli R; Alpatov R; Horton JR; Shi X; Gozani O; Cheng X; Shi Y
    Nature; 2007 Aug; 448(7154):718-22. PubMed ID: 17687328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
    Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
    Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysine-Specific Demethylase 1A (KDM1A/LSD1): Product Recognition and Kinetic Analysis of Full-Length Histones.
    Burg JM; Gonzalez JJ; Maksimchuk KR; McCafferty DG
    Biochemistry; 2016 Mar; 55(11):1652-62. PubMed ID: 26673564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of LSD1 inhibition on self-renewal and differentiation of human induced pluripotent stem cells.
    Yan HJ; Zhou SY; Li Y; Zhang H; Deng CY; Qi H; Li FR
    Exp Cell Res; 2016 Jan; 340(2):227-37. PubMed ID: 26748182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.
    Lillico R; Stesco N; Khorshid Amhad T; Cortes C; Namaka MP; Lakowski TM
    Future Med Chem; 2016 May; 8(8):879-97. PubMed ID: 27173004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Based Identification of Potent Lysine-Specific Demethylase 1 Inhibitor Peptides and Temporary Cyclization to Enhance Proteolytic Stability and Cell Growth-Inhibitory Activity.
    Kitagawa H; Kikuchi M; Sato S; Watanabe H; Umezawa N; Kato M; Hisamatsu Y; Umehara T; Higuchi T
    J Med Chem; 2021 Apr; 64(7):3707-3719. PubMed ID: 33754721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.